In this multidisciplinary, collaborative presentation, we will discuss Expedited Partner Therapy (EPT) and its use as a public health tool in fighting bacterial sexually transmitted infection (STI) rates. EPT is recommended by the CDC and is allowed by the state of Minnesota. We will discuss successes and opportunities for pharmacy and pharmacists to support this proven intervention.
Upon successful completion of this activity, pharmacists and technicians should be able to:
- Review treatment guidelines for chlamydia and gonorrhea sexually-transmitted infections
- Explain Expedited Partner Therapy as an evidence-based intervention
- Discuss Minnesota rules and CDC guidance for use of EPT
- Identify opportunities within different pharmacy practice sites to optimize EPT access
Daniel Jude is a Clinical Pharmacy Specialist with TrellisRx, working within North Memorial Hospital's Infectious Disease Clinic. He has extensive experience with HIV, specialty pharmacy, clinical program management, and community outreach. He currently serves on the Board of Directors for JustUs Health, Minnesota's largest AIDS Service Organization. He also supports MDH and DHS initiatives in other capacities. He is a certified HIV pharmacist and a certified specialty pharmacist. He graduated from the University of Iowa College of Pharmacy in 2008.
Candy Hadsall, RN, MA
Candy Hadsall is the Prevention Nurse Specialist at the Minnesota Department of Health in the STD, HIV & TB Section. In that position, she provides training on STIs at clinics around the state. Candy received her R.N. from Iowa Methodist Medical Center in Des Moines, IA, attended the University of Iowa, and received her B.A. and M.A. at the University of Illinois in Springfield, Illinois. More recently, she helped found the Minnesota Chlamydia Partnership and authored the Minnesota Chlamydia Strategy: Action Plan to Reduce and Prevent Chlamydia in MN with input from over 250 people in Minnesota. She is co-author of Expedited Partner Therapy: A New Strategy for Reducing Sexually Transmitted Diseases in Minnesota that was published in Minnesota Medicine in October 2013.
The cost is $25 for non-members. MPhA pharmacist members, pharmacy technician members and student members may access at no cost.
This presentation is being submitted to the Minnesota Board of Pharmacy for Continuing Education credit approval (one hour).
To receive Board of Pharmacy credits for this program, the following must be completed:
Board of Pharmacy credit processing takes place on the 15th of each month.
||The Minnesota Pharmacists Association is accredited by the Minnesota Board of Pharmacy as a provider of continuing pharmacy education.
Questions? Please contact email@example.com with questions about credits.
Please contact firstname.lastname@example.org with any technical questions or issues.